Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastrointestinal calcium absorption is not a single molecule or receptor, but rather a physiological process by which dietary calcium is taken up from the intestinal lumen into the body. This occurs through two main mechanisms: 1. Transcellular active transport: Predominantly in the duodenum and upper jejunum. It involves entry through apical channels such as TRPV6 (formerly CaT1), intracellular binding to calbindin-D9k, and extrusion across the basolateral membrane via plasma membrane Ca²⁺ ATPase (PMCA). This pathway is tightly regulated by vitamin D—specifically its active metabolite 1,25(OH)₂D₃—which increases expression of key proteins involved in this route[1][3][4][5]. 2. Paracellular passive diffusion: Occurs throughout the small intestine when luminal concentrations are high enough for passive movement between enterocytes via tight junctions. This mechanism is non-saturable and less regulated than transcellular transport[3][7]. The efficiency of gastrointestinal calcium absorption depends on factors including dietary intake level, age, hormonal status (especially vitamin D), intestinal transit time, pH affecting solubility, presence of inhibitors like phytates/oxalates/tannins in food[3], and genetic polymorphisms affecting transporter proteins. While not itself a druggable target or receptor/enzyme/transporter/protein family member—and thus not considered an individual therapeutic target—the underlying molecular components such as TRPV6, calbindin-D9k, plasma membrane Ca²⁺ ATPase, and regulatory elements like the vitamin D receptor are recognized targets for research into bone health disorders including osteoporosis[4][5]. In summary: "Gastrointestinal calcium absorption" refers to an essential physiological function involving multiple coordinated molecules rather than being itself a canonical drug target or molecular entity suitable for structured annotation under typical pharmacological frameworks.
Mechanisms involve modulation of underlying transporters, channels, and regulatory pathways such as vitamin D analogs increasing transcellular transport via upregulation of TRPV6 and calbindin-D9k[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal calcium absorption.